PACS Group, Inc.

NYSE:PACS

Financial - Conglomerates

Financial Services
$46.30 +1.16%

+$0.41 today

Market cap
$7.35B
Beta
0.00
P/E (TTM)
23.0
EPS (TTM)
$1.55
52W Low $7.50High $43.08

Volume 0.78M

Average 0.84M

PACS EBITDA Margin

EBITDA as a percentage of revenue.

PACS Group, Inc.NYSE: PACS

EBITDA Margin · Q2 FY2026 · quarter ended Jun 2026

EBITDA Margin widens to 9.2%

EBITDA Margin was 9.2% in Q2 FY2026, up 1.9 pp from a year earlier. On a trailing-twelve-month basis it was 8.6%, up 2.5 pp year over year. Over 3 fiscal years it narrowed by 3.6 pp.

Context

  • EBITDA Margin widened in 1 of the last 3 fiscal years.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 4 analysts of 12.2% for the fiscal year ending Dec 2026, up from 6.9% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterJun 2026
9.2%-0.5 pp QoQ
Last fiscal yearDec 2025
6.9%+2.3 pp YoY
LTMJun 2026
8.6%+2.5 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+1.9 pp+4.3 pp+2.4 pp
1 year+2.3 pp+5.3 pp+2.9 pp
3 years-3.6 pp+6.9 pp+10.6 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
6.9%
Year-over-year change
+2.3pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How PACS compares with its peers on the latest reported figures

  • PACS's LTM Jun 2026 EBITDA Margin of 8.6% is the 8th highest of the 11 companies compared; the peer median is 13.5%.
  • Its year-over-year change of +2.5 pp is the 3rd highest of 11, against a peer median of +0.5 pp.
  • Over three fiscal years its change of -3.6 pp compares with a peer median of +3.2 pp.
PACS Competitors Peer median
EBITDA Margin for PACS and competitors
Company Period LTM level YoY 3-year change
NUTXNutex Health, Inc.LTM Mar 202633.2% -1.1 pp+212.5 pp
EHCEncompass Health CorporationLTM Jun 202624.2% +1.1 pp+3.6 pp
CYHCommunity Health Systems, Inc.LTM Mar 202623.1% +13.2 pp+6.6 pp
HCAHCA Healthcare, Inc.LTM Jun 202620.3% +0.5 pp-1.4 pp
BKDBrookdale Senior Living Inc.LTM Sep 202614.0% -0.5 pp-0.2 pp
NHCNational HealthCare CorporationLTM Sep 202613.1% +0.5 pp+7.7 pp
ENSGThe Ensign Group, Inc.LTM Jun 202611.3% -0.1 pp-0.7 pp
PACSPACS Group, Inc.LTM Jun 20268.6% +2.5 pp-3.6 pp
LFSTLifeStance Health Group, Inc.LTM Jun 20268.3% +4.0 pp+22.2 pp
PNTGThe Pennant Group, Inc.LTM Mar 20265.9% -0.7 pp+2.7 pp
INNVInnovAge Holding Corp.LTM Mar 20260.5% +1.0 pp-0.9 pp
Peer median (excluding PACS) 13.5%+0.5 pp+3.2 pp

Competitors are the stored peer set for PACS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue1.17B2.42B3.11B4.09B5.29B
Cost of Revenue979.22M2.02B2.66B3.3B4.13B
Gross Profit187.35M400.68M447.07M792.64M1.16B
Gross Margin16.1%16.5%14.4%19.4%21.9%
Research & Development00000
Selling, General & Admin96.83M149.01M213.66M343.81M415.07M
Operating Expenses103.99M171.32M239.3M669.57M849.64M
Depreciation & Amortization7.15M22.31M25.63M40.81M55.66M
EBITDA93.86M254.89M232.87M186.7M365.57M
EBITDA Margin8.0%10.5%7.5%4.6%6.9%
Operating Income83.36M229.36M207.77M123.07M309.6M
Operating Margin7.1%9.5%6.7%3.0%5.9%
Interest Income00000
Interest Expense5.28M25.54M49.92M44.34M28.36M
Other Income / Expenses(1.93M)(22.32M)(50.46M)(21.52M)(25.15M)
Income Before Tax81.43M207.05M157.32M101.55M284.45M
Pre-Tax Margin7.0%8.5%5.1%2.5%5.4%
Income Tax Expense33.48M56.55M44.44M46.21M92.99M
Net Income47.95M150.5M112.87M55.76M191.54M
Net Margin4.1%6.2%3.6%1.4%3.6%
EPS (Basic)0.321.000.750.381.23
EPS (Diluted)0.321.000.750.381.22
Weighted Avg Shares150.15M150.15M150.15M146.66M156.18M
Weighted Avg Shares (Diluted)150.15M150.15M150.15M148.57M156.7M

PACS Group, Inc.

NYSE:PACS

Intrinsic Alpha fair value

Locked

Current Price

$46.30

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.